Showing 5181-5190 of 5956 results for "".
- Caren Mason, CEO of Starr Surgical, Named to Top 50 Healthcare Technology CEOs Of 2020https://modernod.com/news/caren-mason-ceo-of-starr-surgical-named-to-top-50-healthcare-technology-ceos-of-2020/2477827/The Healthcare Technology Report announced The Top 50 Healthcare Technology CEOs of 2020. Data on each CEO’s professional background was gathered and they were assessed across several key areas, including breadth of leadership experience in the healthcare technology industry, level of exper
- InMed Releases CBN Preclinical Results in Glaucomahttps://modernod.com/news/inmed-releases-cbn-preclinical-results-in-glaucoma/2477826/InMed Pharmaceuticals provided an update on the preclinical results from its INM-088 drug development program that indicate a potential neuroprotective effect of cannabinol (CBN) on nerve cells located in the eye. INM-088 is being developed as a potential treatment option for ocular diseases, suc
- Bausch + Lomb Announces European Launch of a New Platform of Preloaded IOLs, LuxSmart and LuxGoodhttps://modernod.com/news/bausch-lomb-announces-the-launch-of-a-new-platform-of-preloaded-iols-luxsmart-and-luxgood/2477823/Bausch + Lomb announced the European launch of the company’s first presbyopia correcting IOL, LuxSmart, and its monofocal version, LuxGood. Both feature preloaded delivery systems and Pure Refractive Optics (PRO) Technology. LuxSmart and LuxGood comprise a hydrophobic material and repres
- Genentech: Longer-Term Data Reinforce Safety of Satralizumab in Adults and Adolescents With NMOSDhttps://modernod.com/news/genentech-longer-term-data-reinforce-safety-of-satralizumab-in-adults-and-adolescents-with-nmosd/2477813/Genentech will present new pooled pivotal satralizumab safety results for the treatment of neuromyelitis optica spectrum disorder (NMOSD), a rare, debilitating central nervous system disorder. These data are being presented at the 6th annual meeting of the European Academy of Neurology (EAN) and
- Mayo Clinic, CommonSpirit, and Mass General Feel Hit From COVID-19 in Q1https://modernod.com/news/mayo-clinic-commonspirit-and-mass-general-feel-hit-from-covid-19-in-q1/2477795/Major health systems the Mayo Clinic, CommonSpirit Health, and Mass General Brigham revealed the first details on how the COVID-19 pandemic is hitting them financially, with some systems reporting millions in losses, according to a FierceHealthcare
- Market Scope: Premium IOLs Expected to Drive Market Growth Over the Next 5 Yearshttps://modernod.com/news/market-scope-premium-iols-expected-to-drive-market-growth-over-the-next-5-years/2477796/The revenue contribution of premium IOLs is expected to grow over the next 5 years as the number and different types of IOL designs offered to cataract and refractive patients seeking better visual outcomes increases, according to a Market Scope report. In 2019, premium IOLs accounted a th
- Atia Vision Closes Second Tranche Of $20M In Series D Financinghttps://modernod.com/news/atia-vision-closes-second-tranche-of-20m-in-series-d-financing/2477793/Atia Vision, which is developing of a modular presbyopia-correcting accommodating IOL, announced the closing of its second tranche of a Series D $20M financing. The financing will be used to continue early clinical experience treating cataract patients and support ex
- Kubota Vision Introduces Electronic Eyeglasses to Stop Myopia in Childrenhttps://modernod.com/news/kubota-vision-introduces-electronic-eyeglasses-to-stop-myopia-in-children/2477794/Kubota Vision announced positive clinical results from myopia control tests in humans. Utilizing electronic tabletop optical projection devices that embody Kubota Glasses technology, myopically-defocused images were projected on the peripheral retina of subjects to study if progression of myopia
- Avellino Announces A.C.T.S. Program to Help Eye Care and Other Surgical Practices Protect Patients and Staff From COVID-19https://modernod.com/news/avellino-announces-a-c-t-s-program-to-help-eye-care-and-other-surgical-practices-protect-patients-and-staff-from-covid-19/2477792/Avellino announced the rollout of the new A.C.T.S. Program (Active Coronavirus Testing & Safety) designed to help ophthalmology and other elective surgery and procedure-oriented practices safely reopen and resume care while protecting patients and staff from COVID-19 virus transmission. <
- Early Data Show Moderna’s COVID-19 Vaccine Generates Immune Responseshttps://modernod.com/news/first-covid-19-vaccine-tested-in-the-us-shows-promise-in-data-from-eight-people/2477791/Moderna reported positive interim data from a phase 1 study of its vaccine candidate against SARS-CoV-2, with results showing that mRNA-1273 elicited neutralizing antibody titer levels in all eight initial participants in the low- and mid-dose cohorts, reaching or exceeding levels generally seen